NU-TRIHEXYPHENIDYL 2 MG
TRIHEXYPHENIDYL HYDROCHLORIDE : 2 MG · DIN 02239235 · NU-PHARM INC
Health Canada status: CANCELLED (UNRETURNED ANNUAL)
What is NU-TRIHEXYPHENIDYL?
NU-TRIHEXYPHENIDYL 2 MG contains TRIHEXYPHENIDYL HYDROCHLORIDE : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02239235, held by NU-PHARM INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled (unreturned annual), status dated 28-Mar-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02239235 |
|---|---|
| Brand name | NU-TRIHEXYPHENIDYL |
| Generic / active ingredient | TRIHEXYPHENIDYL HYDROCHLORIDE : 2 MG |
| Manufacturer | NU-PHARM INC |
| Strength | 2 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N04AA01 TRIHEXYPHENIDYL |
| AHFS class | 84:04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED (UNRETURNED ANNUAL) |
| Status date | 28-Mar-2018 |
| Original market date | 1999-02-09 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N04AA01 TRIHEXYPHENIDYL. 2 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TRIHEXYPHENIDYL | 2 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00545058 |
| TRIHEXYPHENIDYL | 5 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00545074 |
| APARKANE TAB 2MG | 2 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00280445 |
| APARKANE TAB 5MG | 5 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00271314 |
| ARTANE ELX 2MG/5ML | 2 MG / 5 ML | ELIXIR | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00014656 |
| ARTANE TAB 2MG | 2 MG | TABLET | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00015040 |
| ARTANE TAB 5MG | 5 MG | TABLET | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00015059 |
| NOVO-HEXIDYL 2MG | 2 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00021911 |
| NOVO-HEXIDYL 5MG | 5 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00021938 |
| NU-TRIHEXYPHENIDYL | 5 MG | TABLET | NU-PHARM INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02239236 |
Who else supplies TRIHEXYPHENIDYL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRIHEXYPHENIDYL appears in 8 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.